Dialysis and Pregnancy: Optimizing Therapy for Best Maternal and Fetal Outcomes

IF 1.4 4区 医学 Q3 UROLOGY & NEPHROLOGY
Hemodialysis International Pub Date : 2026-07-09 Epub Date: 2026-03-08 DOI:10.1111/hdi.70062
Shreepriya Mangalgi, Silvi Shah
{"title":"Dialysis and Pregnancy: Optimizing Therapy for Best Maternal and Fetal Outcomes","authors":"Shreepriya Mangalgi,&nbsp;Silvi Shah","doi":"10.1111/hdi.70062","DOIUrl":null,"url":null,"abstract":"<p>Pregnancy in women with end-stage kidney disease (ESKD) requiring dialysis remains high risk, with significant maternal and fetal complications. While fertility rates are markedly reduced in this population, advances in dialysis care and obstetric management have led to increasing reports of successful pregnancies. Important maternal adverse outcomes include early pregnancy loss, preeclampsia, polyhydramnios, and cesarean delivery, while common adverse fetal outcomes are preterm birth, low birth weight, and high neonatal intensive care utilization. Evidence consistently demonstrates that dialysis intensification—achieving longer treatment hours or targeting lower maternal blood urea nitrogen levels—correlates with improved gestational age and birth weight, thereby enhancing live birth rates. Optimizing therapy further requires individualized dialysis prescriptions, careful volume and blood pressure management, and timely adjustment of dialysate composition. A multidisciplinary approach involving nephrology, maternal-fetal medicine, obstetrics, gynecology, and neonatology is critical for care coordination. Despite these advances, significant disparities persist, particularly in access to intensive dialysis and specialized care worldwide. Future directions include strengthening obstetric nephrology training, expanding research in peritoneal and home hemodialysis during pregnancy, and establishing integrated care models. With careful planning and optimization of renal replacement therapy, maternal and fetal outcomes in this high-risk population can continue to improve. This review aims to synthesize current evidence on fertility, dialysis strategies, and maternal–fetal outcomes in pregnant women with ESKD on dialysis, while highlighting practical considerations for dialysis optimization and multidisciplinary care, thereby addressing gaps in consolidated guidance for clinicians managing this increasingly encountered high-risk population.</p>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"30 3","pages":"499-507"},"PeriodicalIF":1.4000,"publicationDate":"2026-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hdi.70062","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hemodialysis International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hdi.70062","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Pregnancy in women with end-stage kidney disease (ESKD) requiring dialysis remains high risk, with significant maternal and fetal complications. While fertility rates are markedly reduced in this population, advances in dialysis care and obstetric management have led to increasing reports of successful pregnancies. Important maternal adverse outcomes include early pregnancy loss, preeclampsia, polyhydramnios, and cesarean delivery, while common adverse fetal outcomes are preterm birth, low birth weight, and high neonatal intensive care utilization. Evidence consistently demonstrates that dialysis intensification—achieving longer treatment hours or targeting lower maternal blood urea nitrogen levels—correlates with improved gestational age and birth weight, thereby enhancing live birth rates. Optimizing therapy further requires individualized dialysis prescriptions, careful volume and blood pressure management, and timely adjustment of dialysate composition. A multidisciplinary approach involving nephrology, maternal-fetal medicine, obstetrics, gynecology, and neonatology is critical for care coordination. Despite these advances, significant disparities persist, particularly in access to intensive dialysis and specialized care worldwide. Future directions include strengthening obstetric nephrology training, expanding research in peritoneal and home hemodialysis during pregnancy, and establishing integrated care models. With careful planning and optimization of renal replacement therapy, maternal and fetal outcomes in this high-risk population can continue to improve. This review aims to synthesize current evidence on fertility, dialysis strategies, and maternal–fetal outcomes in pregnant women with ESKD on dialysis, while highlighting practical considerations for dialysis optimization and multidisciplinary care, thereby addressing gaps in consolidated guidance for clinicians managing this increasingly encountered high-risk population.

Abstract Image

透析和妊娠:优化治疗的最佳母婴结局。
需要透析的终末期肾病(ESKD)妇女妊娠的风险仍然很高,有明显的母体和胎儿并发症。虽然这一人口的生育率明显下降,但透析护理和产科管理的进步导致成功怀孕的报告越来越多。重要的孕产妇不良结局包括早孕流产、先兆子痫、羊水过多和剖宫产,而常见的胎儿不良结局是早产、低出生体重和新生儿重症监护使用率高。证据一致表明,强化透析——延长治疗时间或降低母体血尿素氮水平——与改善胎龄和出生体重相关,从而提高活产率。进一步优化治疗需要个性化的透析处方,仔细的容积和血压管理,及时调整透析液成分。涉及肾脏病学、母胎医学、产科、妇科和新生儿学的多学科方法对护理协调至关重要。尽管取得了这些进展,但显著的差距仍然存在,特别是在世界各地获得强化透析和专科护理方面。未来的发展方向包括加强产科肾脏病学培训,扩大妊娠期腹膜和家庭血液透析的研究,建立综合护理模式。通过精心规划和优化肾脏替代治疗,这一高危人群的母婴结局可以继续改善。本综述旨在综合目前关于ESKD孕妇透析的生育能力、透析策略和母胎结局的证据,同时强调透析优化和多学科护理的实际考虑,从而解决临床医生管理这一日益遇到的高风险人群的综合指导的空白。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hemodialysis International
Hemodialysis International UROLOGY & NEPHROLOGY-
CiteScore
2.50
自引率
0.00%
发文量
58
审稿时长
6-12 weeks
期刊介绍: Hemodialysis International was originally an annual publication containing the Proceedings of the International Symposium on Hemodialysis held in conjunction with the Annual Dialysis Conference. Since 2003, Hemodialysis International is published quarterly and contains original papers on clinical and experimental topics related to dialysis in addition to the Annual Dialysis Conference supplement. This journal is a must-have for nephrologists, nurses, and technicians worldwide. Quarterly issues of Hemodialysis International are included with your membership to the International Society for Hemodialysis. The journal contains original articles, review articles, and commentary to keep readers completely updated in the field of hemodialysis. Edited by international and multidisciplinary experts, Hemodialysis International disseminates critical information in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书